Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients

Chest

Volumn 113, Issue 4, 1998, Pages 900-905

  Serres, Isabelle ^a,b   Gautier, Véronique ^a   Varray, Alain ^b   Préfaut, Christian ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Body composition; COPD; Deconditioning; Endurance; Physical activity questionnaire; Skeletal muscle; Strength

Indexed keywords

ADULT; ARTICLE; BICYCLE ERGOMETRY; BODY COMPOSITION; BODY PLETHYSMOGRAPHY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDURANCE; HUMAN; IMMOBILIZATION; LUNG FUNCTION TEST; MALE; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0031966229     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.4.900     Document Type: Article

References (30)

1. Dillard TA, Piantadosi S, Rajagopal KR. Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest 1989; 96:267-71
2. Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935-40
3. Young A. Rehabilitation of patients with pulmonary disease. Ann Acad Med 1983; 12:410-16
4. Préfaut Ch, Varray A, Vallet G. Pathophysiological basis of exercise training in patients with chronic obstructive lung disease. Eur Respir Rev 1995; 5:27-32
5. Tada H, Kato H, Misawa T, et al. P-Nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur Respir J 1992; 5:163-69
6. Wuyam B, Payen JF, Lew P, et al. Metabolism and aerobic capacity in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 1992; 5:157-62
7. Gollnick PD, Saltin B. Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin Physiol 1982; 2:1-12
8. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152:2021-31
9. Gosselink R, Troosters T, Decramer M. Peripheral muscle contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153:976-80
10. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chron Dis 1985; 38:517-24
11. Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 1221:823-32
12. Siafakas NM, Vermeire P, Pride NB, et al. EHS consensus statement: optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398-1420
13. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993: 6(suppl 16):5-40
14. Monod H, Scherrer J. The work capacity of a synergic muscular group. Ergonomies 1965; 329-38
15. Voorips LE, Ravelli ACJ, Dongelmans PCA, et al. A physical activity questionnaire for the elderly. Med Sci Sports Exerc 1991; 8:974-79
16. Lukaski HC, Johnson PE, Bolonchuk WW, et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41:810-17
17. Schols AMWJ, Dingemans AMC, Soeters PB, et al. Body composition by bioelectrical impedance analysis compared to deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53:421-24
18. Jones NL, Makrides L, Hitchcock C, et al. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131:700-08
19. Wasserman K, Hansen J, Sue D, et al. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger, 1986
20. Serres I, Varray A, Vallet G, et al. Improved skeletal muscle performance after individualized exercise training in patients with COPD. J Cardiopulmonary Rehabil (in press)
21. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:374-77
22. Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288-93
23. Sahlin K, Edstrom L, Sjoholm H, et al. Effects of lactic acid accumulation and ATP decrease on muscle tension and relaxation. Am J Physiol 1981; 240:C121-26
24. 31P Nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue. J Clin Invest 1988; 81:1190-96
25. Tittel K, Wutscherk H. Biological basis for strength and power: anthropometric factors. In: Komi PV. Strength and power in sports. Oxford: Blackwell Scientific Publications, 1992; 180-96
26. Kutsuzawa T, Shioya S, Kurita D, et al. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. Am J Respir Grit Care Med 1995; 152:647-52
27. Coyle EF, Martin WH III, Sinacore DR, et al. Time course of loss of adaptations after stopping prolonged intense endurance training. J Appl Physiol 1984; 57:1857-64
28. Lasson L, Ansved T. Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man. Muscle Nerve 1985; 8:714-22
29. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990; 3:192-96
30. 31P-MRS. J Appl Physiol 1995; 78:2218-27